Search

Your search keyword '"Dwek, Ra"' showing total 44 results

Search Constraints

Start Over You searched for: Author "Dwek, Ra" Remove constraint Author: "Dwek, Ra" Topic immunoglobulin g Remove constraint Topic: immunoglobulin g
44 results on '"Dwek, Ra"'

Search Results

1. Selective deactivation of serum IgG: a general strategy for the enhancement of monoclonal antibody receptor interactions.

2. Increased levels of galactose-deficient anti-Gal immunoglobulin G in the sera of hepatitis C virus-infected individuals with fibrosis and cirrhosis.

Catalog

Books, media, physical & digital resources

3. Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG.

4. Glycan analysis of monoclonal antibodies secreted in deposition disorders indicates that subsets of plasma cells differentially process IgG glycans.

5. Immunology. Sugar determines antibody activity.

6. Crystal structure of an intact human IgG: antibody asymmetry, flexibility, and a guide for HIV-1 vaccine design.

7. Contrasting IgG structures reveal extreme asymmetry and flexibility.

8. Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design.

9. Sugar printing rheumatic diseases: a potential method for disease differentiation using immunoglobulin G oligosaccharides.

10. Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides.

11. Site-specific glycosylation of human immunoglobulin G is altered in four rheumatoid arthritis patients.

12. Glycobiology: 'the function of sugar in the IgG molecule'.

13. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein.

14. Agalactosyl glycoforms of IgG autoantibodies are pathogenic.

15. Diversification of the IgG molecule by oligosaccharides.

16. Analysis of glycosylation changes in IgG using lectins.

17. Agalactosyl IgG, antibodies to heat shock proteins, and acute rheumatic fever.

18. Structures of the sugar chains of rabbit immunoglobulin G: occurrence of asparagine-linked sugar chains in Fab fragment.

19. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG.

20. A novel approach to water proton relaxation in paramagnetic ion-macromolecule complexes.

21. The effect of aglycosylation on the binding of mouse IgG to staphylococcal protein A.

22. Changes in carbohydrate structure of IgG in rheumatoid arthritis.

23. The determination of molecular-motion parameters from proton-relaxation-enhancement measurements in a number of Gd(III) - antibody-fragment complexes. A comparative study.

24. Specific spin labelling of the Fc region of immunoglobulins.

25. Formation of complement subcomponent C1q-immunoglobulin G complex. Thermodynamic and chemical-modification studies.

26. The Clq receptor site on immunoglobulin G.

27. The isolation of a globular fragment of rabbit immunoglobulin G probably corresponding to the intact C gamma 2 homology region.

28. The interaction of protein A and Fc fragment of rabbit immunoglobulin G as probed by complement-fixation and nuclear-magnetic-resonance studies.

29. Binding of complement subcomponent C1q to mouse IgG1, IgG2a and IgG2b: a novel C1q binding assay.

30. The binding of lanthanides to non-immune rabbit immunoglobulin G and its fragments.

31. Chemical verification of the C1q receptor site on IgG.

32. Galactosylation of IgG associated oligosaccharides.

34. The role of IgG glycoforms in the pathogenesis of rheumatoid arthritis.

35. The analysis of coupling networks in a complex oligosaccharide mixture derived from the Fc region of rabbit immunoglobulin G using 1H-1H correlated NMR spectroscopy combined with double quantum NMR spectroscopy.

36. Comment on the article by Tomana et al.

37. The use of gadolinium as a probe in the Fc region of a homogeneous anti-(type-III pneumococcal polysaccharide) antibody.

39. Immunoglobulin G as a glycoprotein.

40. Effector functions of a monoclonal aglycosylated mouse IgG2a: binding and activation of complement component C1 and interaction with human monocyte Fc receptor.

41. Difficulties in determining accurate molecular motion parameters from proton relaxation enhancement measurements as illustrated by the immunoglobulin G-Gd(III) system.

42. Galactosylation of IgG associated oligosaccharides: reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity.

44. The use of protein A and concanavalin A to examine the possible role of the carbohydrate of IgG in the binding of Clq.